JPRN-C000000415已完成未知
Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer - Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Symptomatic brain metastasis SVC symdrome
研究者
相似试验
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer.KRAS wild-type metastatic colon cancer.JPRN-UMIN000005368iigata Colorectal cancer Chemotherapy Study Group (NCCSG)25
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.metastatic colorectal cancerJPRN-UMIN000001631iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
未知
1 期
Phase1study of a combination of CPT-11 and TS-1 and bevacizumab in patients with metastatic colon cancermetastatic colorectal cancerJPRN-UMIN000001219Department of Surgery, Suita Municipal Hospital24
已完成
2 期
Phase II study of a combination of modified CPT-11 and 5-FU/l-LV (mJIFL) in patients with meatastatic colorectal cancerMeatastatic colorectal cancerJPRN-UMIN000000727OGSG54
招募中
不适用
Randomized phase II study of CPT-11 plus TS-1 plus Cetuximab for advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild type (OGSG 0901)advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild typeJPRN-UMIN000002695Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35